26 Top Dividend Stocks to Buy and Hold in 2026

The author publishes a 26-stock buy-and-hold dividend list for 2026 emphasizing income and selective growth exposure: Dividend Kings such as AbbVie ($405B, 3%), Coca‑Cola ($301B, 2.9%) and Walmart ($888B, 0.8%); tax-advantaged payers Ares Capital (ARCC, 9.5%) and Realty Income (O, 5.7% monthly); Mag7 growth names including Alphabet (0.27%), Apple (0.38%) and Microsoft (0.75%) highlighted for AI upside; and high-yield energy and midstream picks (Energy Transfer 8%, Enterprise Products Partners 6.8%, Enbridge 5.8%—noted for transporting ~30% of North American crude). The list also flags utility and renewable holdings (multiple Brookfield tickers), value dividend plays like Pfizer (6.9%), UPS (6.6%) and Verizon (6.8%), and an ultra-high-yield closed-end fund FS Credit Opportunities (FSCO, 12.8%); the author notes several names trade at forward P/E multiples below the S&P 500, framing the slate for income-focused allocations with selective growth exposure.

Analysis

Market structure: The article signals rotation into high-yield income (ARCC 9.5%, FSCO 12.8%, EPD 6.8%, ENB 5.8%) and selective growth (GOOGL, AAPL, MSFT). Direct winners: midstream pipelines (ENB, EPD), BDCs/CEFs (ARCC, FSCO) and monthly REITs (O) that benefit from steady cash returns; losers are long-duration growth without yield support and cyclical capex names if rates stay elevated. Expect relative share gains for tolling/midstream players vs commodity-price-dependent E&Ps, tightening pricing power for pipeline owners as takeaway capacity becomes scarce.

Risk assessment: Tail risks include regulatory/drug-pricing shocks for ABBV/PFE, a major spill or tariff ruling for ENB, and rapid credit spread widening that would hit BDCs/CEFs hard; probability low but impact high (>20% equity moves). Near-term (days–weeks): Fed guidance and Q1 earnings will reprice yields; short-term (3–6 months): credit-cycle signals and oil/GDP growth drive performance; long-term (12–36 months): secular AI for GOOGL/MSFT and energy transition pressure on hydrocarbon midstream cash flows.

Trade implications: Cross-assets matter — a 50bp move in 10y yields can compress REIT/utility P/Es by 5–10% and widen BDC spreads by 150–300bp; oil +20% would materially boost midstream FCF. Use covered-call income on stable high-yield names, LEAPS for concentrated AI upside (GOOGL), and put spreads to hedge BDC/CEF credit exposure; size exposures to 1–3% notional with clearly defined stop-losses and re-entry rules.

Contrarian angles: Consensus underprices credit/structure risk in ultra-high yields — FSCO and ARCC yields reflect material NAV and leverage risk that could widen quickly if rates surprise; Brookfield LP/Corp pairings hide tax and cashflow asymmetries that could compress LP discounts. UnitedHealth (UNH) appears under-owned post-2025 weakness and is a tactical contrarian long if fundamentals hold, while some energy names may be over-loved if commodity-backed volumes decline.

Key Decisions for Investors

• Establish a 3% portfolio long split 60/40 ENB (1.8%) / EPD (1.2%), accumulate on pullbacks >8% or if forward yield rises +50bp, target 12–24 month hold to capture distribution growth and buyback optionality.
• Allocate 1.5% notional to GOOGL Jan 2028 LEAPS (delta ~0.30–0.40) as a concentrated AI growth bet; scale in on 5–10% pullbacks and review at each quarterly earnings release.
• Implement income overlay: initiate covered-call program on Realty Income (O) and Verizon (VZ) — sell 30–45 day calls ~3% OTM, roll monthly, target incremental ~3–5% annualized premium, and close positions if underlying drops >12%.
• Avoid outright long in FSCO and keep it <0.5% position unless NAV discount >8% and fund reduces leverage; instead, buy a 3–6 month put spread on FSCO sized 0.5% notional (10%/20% OTM strikes) to protect against discount blowout or credit stress.